S&P also affirmed the “A+” rating on Deaconess’ series 2011A, 2013A and 2015A fixed rate revenue bonds.
“The ‘A+’ rating continues to reflect our view of Deaconess’ exceptional pro forma maximum annual debt service, excellent business position, remarkable cash flow and improving balance sheet ratios,” said S&P analyst Brian Williamson.
The outlook is stable, reflecting S&P’s view that while Deaconess constructs a new patient tower and medical office building, it will maintain stellar operating performance, a solid balance sheet and a favorable business position.
More articles on healthcare finance:
HealthTrust taps iMedX, Zotec adds orthopedic client & more — 6 RCM keynotes
The clinician’s role in RCM: 3 questions with McKesson’s Dan Mowery
Craneware reports double-digit revenue growth in FY 2016
